Researchers in Taiwan have developed a new targeted therapy drug that preclinical trials suggest could inhibit the growth of tumors in nearly 30 percent of cancer patients.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Brief rain is possible in Taiwan on Saturday
04/26/2025 12:24 PM - Society
Taiwan headline news
04/26/2025 11:13 AM - Politics
Ex-Japanese vice minister denies making remarks about Taiwan's President Lai
04/25/2025 11:16 PM - Sports
Taiwan's judoka settles for silver at Asian championships
04/25/2025 10:11 PM - Society
Court detains KMT official in recall petition forgery case
04/25/2025 08:49 PM